☆ 4.4 Editorial Material

Anti-flagellin antibodies in irritable bowel syndrome: another attack on our commensals?

NEUROGASTROENTEROLOGY AND MOTILITY (2008)

期刊

NEUROGASTROENTEROLOGY AND MOTILITY

卷 20, 期 10, 页码 1081-1085

出版社

WILEY-BLACKWELL

DOI: 10.1111/j.1365-2982.2008.01199.x

关键词

flagellin; inflammatory bowel disease; irritable bowel syndrome

类别

Gastroenterology & Hepatology Clinical Neurology Neurosciences

向作者/读者索取更多资源

Protocol

社区支持

Reagent

社区支持

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

主要评分

4.4

评分不足

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

(Poly)phenols in Inflammatory Bowel Disease and Irritable Bowel Syndrome: A Review

Marilyn Hagan, Bu' Hussain Hayee, Ana Rodriguez-Mateos

Summary: Polyphenols (PPs) may have therapeutic benefits in gastrointestinal (GI) disorders like IBS or IBD, but the evidence base is inconsistent and further research is needed to clarify their effects.

MOLECULES (2021)

添加到收藏夹

Article Dermatology

Isotretinoin and the risk of inflammatory bowel disease and irritable bowel syndrome: A large-scale global study

Khalaf Kridin, Ralf J. Ludwig

Summary: Isotretinoin does not increase the risk of Crohn's disease, but it may be associated with a slight and temporary increase in the risk of ulcerative colitis. However, it can lower the risk of irritable bowel syndrome.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2023)

添加到收藏夹

Article Health Care Sciences & Services

Irritable Bowel Syndrome Is an Independent Risk Factor for Developing Opioid Use Disorder in Patients with Inflammatory Bowel Disease

Yuhan Fu, Michael Kurin, Marc Landsman, Ronnie Fass, Gengqing Song

Summary: The aim of the study was to determine whether IBS is an independent risk factor for developing opioid addiction and related gastrointestinal symptoms in patients with IBD. The results showed that patients with concomitant IBD and IBS were more likely to be prescribed oral opioids and develop opioid dependence or abuse.

JOURNAL OF PERSONALIZED MEDICINE (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Gut microbiota in mucosa and feces of newly diagnosed, treatment-naive adult inflammatory bowel disease and irritable bowel syndrome patients

Hana Cipcic Paljetak, Anja Baresic, Marina Panek, Mihaela Peric, Mario Matijasic, Ivana Lojkic, Ana Barisic, Darija Vranesic Bender, Dina Ljubas Kelecic, Marko Brinar, Mirjana Kalauz, Marija Milicevic, Dora Grgic, Niksa Turk, Irena Karas, Silvija Cukovic-Cavka, Zeljko Krznaric, Donatella Verbanac

Summary: This study compares the differences in gut microbiota between newly diagnosed, treatment-naive adult inflammatory bowel disease (IBD) patients (CD and UC) with irritable bowel syndrome (IBS) patients and healthy individuals. The results show that changes in gut microbiota are detectable at the onset of disease and may play a significant role in the development of IBD.

GUT MICROBES (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis

Arjun Gandhi, Ayesha Shah, Michael P. Jones, Natasha Koloski, Nicholas J. Talley, Mark Morrison, Gerald Holtmann

Summary: The systematic review and meta-analysis indicated that methane-positive SIBO is more prevalent in IBS, particularly in IBS-C, compared to controls, while it is less common in patients with IBD. In patients with IBD, methane-positive SIBO was significantly lower in Crohn's disease compared to ulcerative colitis. More studies are needed to establish a causal relationship due to the low quality of evidence and clinical heterogeneity in the current studies.

GUT MICROBES (2021)

添加到收藏夹

Article Psychology, Biological

Lower gastric sensitivity in quiescent inflammatory bowel disease than in irritable bowel syndrome

Andre Schulz, Sina-Katharina Welsch, Sarah Etringer, Greta Hansen, Lea Milbert, Jochen Schneider, Gennaro Taddei, Raquel Gomez Bravo, Charilaos Lygidakis, Zoe van Dyck, Annika Lutz, Paul Wilmes, Claus Vogele

Summary: This study investigates whether IBD and IBS patients have altered perception of 'natural' gastric distensions. The results show that IBD patients drink significantly more water until satiation than IBS patients, suggesting relative gastric hypersensitivity in IBS and relative hyposensitivity in IBD patients.

PHYSIOLOGY & BEHAVIOR (2023)

添加到收藏夹

Article Medicine, General & Internal

Inflammatory bowel disease is causally related to irritable bowel syndrome: a bidirectional two-sample Mendelian randomization study

Haoran Ke, Zitong Li, Qianyun Lin, Zefeng Shen, Ye Chen, Jinjun Chen

Summary: This study aimed to determine the causal association between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) using genetic associations and Mendelian randomization analyses. The results showed that genetically predicted IBD was associated with an increased risk of IBS, but no association between genetically influenced IBS and IBD was identified. This study confirms the causal relationship between IBD and IBS, which may impact the diagnosis and treatment of both diseases.

FRONTIERS IN MEDICINE (2023)

添加到收藏夹

Article Nutrition & Dietetics

Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients

Marlijne C. G. de Graaf, Corinne E. G. M. Spooren, Evelien M. B. Hendrix, Martine A. M. Hesselink, Edith J. M. Feskens, Agnieszka Smolinska, Daniel Keszthelyi, Marieke J. Pierik, Zlatan Mujagic, Daisy M. A. E. Jonkers

Summary: The study found that diet quality was lower in patients with IBD and IBS, and was associated with intestinal inflammation and gastrointestinal symptoms to varying degrees.

NUTRIENTS (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults

Elton Dajti, Leonardo Frazzoni, Veronica Iascone, Matteo Secco, Amanda Vestito, Lorenzo Fuccio, Leonardo Henry Eusebi, Pietro Fusaroli, Fernando Rizzello, Carlo Calabrese, Paolo Gionchetti, Franco Bazzoli, Rocco Maurizio Zagari

Summary: Faecal calprotectin is a reliable test with high sensitivity and specificity for distinguishing patients with inflammatory bowel disease from those with irritable bowel syndrome. It seems to have a better sensitivity in Western countries and at a cut-off of <= 50 mu g/g.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms

Xiufang Cui, Haiyang Wang, Ziping Ye, Yi Li, Xinyun Qiu, Hongjie Zhang

Summary: Analysis of the intestinal microbiota revealed that in Crohn's disease patients in remission with IBS-type symptoms, there was a significant increase in Faecalibacterium and a decrease in Fusobacterium. However, in ulcerative colitis patients in remission, the changes in the abundance and structure of the gut microbiota did not explain the occurrence of IBS-type symptoms.

BMC GASTROENTEROLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Diagnostic Implications of Irritable Bowel Syndrome Is an Independent Risk Factor for Undergoing Surgical Interventions in Patients with Inflammatory Bowel Disease

Yuhan Fu, Nisheet Waghray, Ronnie Fass, Gengqing Song

Summary: This study found that patients with inflammatory bowel disease (IBD) who also have irritable bowel syndrome (IBS) are more likely to develop IBD-related complications and undergo surgical interventions. This suggests that IBS is an independent risk factor for the development of complications and surgeries in IBD patients.

DIAGNOSTICS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial

Daniel R. Hoekman, Arine M. Vlieger, Pieter C. Stokkers, Nofel Mahhmod, Svend Rietdijk, Nanne K. de Boer, Tim G. de Meij, Carla Frankenhuis, Geert R. D'Haens, Marc A. Benninga

Summary: The study found that gut-directed hypnotherapy was not superior to standard medical treatment in treating IBS-type symptoms in IBD patients, suggesting that both treatment strategies are reasonable options from a clinical perspective.

JOURNAL OF CROHNS & COLITIS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Post COVID-19 irritable bowel syndrome

Giovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, Giulia Cacciari, Francesca Falangone, Anna Kagramanova, Dmitry Bordin, Vasile Drug, Egidia Miftode, Pietro Fusaroli, Salem Youssef Mohamed, Chiara Ricci, Massimo Bellini, Mohammed Masudur Rahman, Luigi Melcarne, Javier Santos, Beatriz Lobo, Serhat Bor, Suna Yapali, Deniz Akyol, Ferdane Pirincci Sapmaz, Yonca Yilmaz Urun, Tugce Eskazan, Altay Celebi, Huseyin Kacmaz, Berat Ebik, Hatice Cilem Binicier, Mehmet Sait Bugdayci, Munkhtsetseg Banzragch Yagci, Husnu Pullukcu, Berrin Yalinbas Kaya, Ali Tureyen, Ibrahim Hatemi, Elif Sitre Koc, Goktug Sirin, Ali Riza Caliskan, Goksel Bengi, Esra Ergun Alis, Snezana Lukic, Meri Trajkovska, Keren Hod, Dan Dumitrascu, Antonello Pietrangelo, Elena Corradini, Magnus Simren, Jessica Sjoelund, Navkiran Tornkvist, Uday C. Ghoshal, Olga Kolokolnikova, Antonio Colecchia, Jordi Serra, Giovanni Maconi, Roberto De Giorgio, Silvio Danese, Piero Portincasa, Antonio Di Sabatino, Marcello Maggio, Elena Philippou, Yeong Yeh Lee, Daniele Salvi, Alessandro Venturi, Claudio Borghi, Marco Zoli, Paolo Gionchetti, Pierluigi Viale, Vincenzo Stanghellini, Giovanni Barbara

Summary: This study aimed to evaluate the prevalence of gastrointestinal symptoms and post-COVID-19 disorders of gut-brain interaction among hospitalized patients with SARS-CoV-2 infection. The results showed that patients with COVID-19 had higher rates of gastrointestinal symptoms on hospital admission and lower rates of constipation and hard stools at 12 months post-infection compared to the control group. Additionally, the rate of irritable bowel syndrome was significantly higher in patients with COVID-19 than in controls.

GUT (2023)

添加到收藏夹

Review Nutrition & Dietetics

Vitamin D Supplementation and Mental Health in Inflammatory Bowel Diseases and Irritable Bowel Syndrome Patients: A Systematic Review

Dominika Glabska, Aleksandra Kolota, Katarzyna Lachowicz, Dominika Skolmowska, Malgorzata Stachon, Dominika Guzek

Summary: Inflammatory bowel diseases (IBDs) and irritable bowel syndrome (IBS) are associated with decreased quality of life and mental health problems. Vitamin D supplementation is considered to be effective in improving mental health in affected individuals. Studies have shown a positive effect of vitamin D supplementation on the mental health of IBD and IBS patients, but further research is needed for confirmation.

NUTRIENTS (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Nightshade Vegetables: A Dietary Trigger for Worsening Inflammatory Bowel Disease and Irritable Bowel Syndrome?

Rebecca Kuang, David J. Levinthal, Amir A. Ghaffari, Claudia Ramos del Aguila de Rivers, Aylin Tansel, David G. Binion

Summary: The Solanaceae family of plants, commonly known as Nightshade vegetables, have significant culinary, economic, and cultural importance. However, some compounds derived from Nightshades may have adverse effects on human health, including intestinal damage and activation of mast cells. Edible Nightshades are gaining attention as potential triggers for gut symptoms in gastrointestinal disorders.

DIGESTIVE DISEASES AND SCIENCES (2023)

添加到收藏夹

Review Cell Biology

How do immune and mesenchymal cells influence the intestinal epithelial cell compartment in inflammatory bowel disease? Let's crosstalk about it!

William D. Rees, Laura M. Sly, Theodore S. Steiner

JOURNAL OF LEUKOCYTE BIOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Patient Experiences with Clostridioides difficile Infection: Results of a Canada-Wide Survey

Jens Vent-Schmidt, Gail P. Attara, Daniel Lisko, Theodore S. Steiner

PATIENT PREFERENCE AND ADHERENCE (2020)

添加到收藏夹

Article Microbiology

Mycobacterium aviumSubspeciesparatuberculosisInfects and Replicates within Human Monocyte-Derived Dendritic Cells

William D. Rees, Ana C. Lorenzo-Leal, Theodore S. Steiner, Horacio Bach

MICROORGANISMS (2020)

添加到收藏夹

Article Infectious Diseases

Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial

Guy de Bruyn, David L. Gordon, Theodore Steiner, Paul Tambyah, Catherine Cosgrove, Mark Martens, Ehab Bassily, Eng-Soon Chan, Dhaval Patel, Josh Chen, Julian Torre-Cisneros, Carlos Fernando De Magalhaes Francesconi, Richard Gesser, Robert Jeanfreau, Odile Launay, Thelma Laot, Rayo Morfin-Otero, Ernesto Oviedo-Orta, Yoon Soo Park, Franco M. Piazza, Christine Rehm, Enrique Rivas, Steve Self, Sanjay Gurunathan

Summary: A phase 3 multicentre, observer-blind, randomised, controlled trial was conducted to evaluate the efficacy, immunogenicity, and safety of a toxoid vaccine candidate for Clostridioides difficile infection. However, the study was terminated after showing that the bivalent C difficile toxoid vaccine did not prevent C difficile infection, leading to the discontinuation of its clinical development.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Enhances Adaptive Immunity to C difficile Toxin B

Laura Cook, William D. Rees, May Q. Wong, Hannah Peters, Megan K. Levings, Theodore S. Steiner

GASTROENTEROLOGY (2021)

添加到收藏夹

Article Biochemical Research Methods

A method for expansion and retroviral transduction of mouse regulatory T cells

Dan Wu, May Q. Wong, Jens Vent-Schmidt, Dominic A. Boardman, Theodore S. Steiner, Megan K. Levings

Summary: This study describes a new method for purifying, expanding, and retrovirally transducing mouse Tregs, and confirms the feasibility of the method in experiments. By using this method, it is possible to study transduced Tregs in animal models, providing a new avenue for research on genetically engineered Treg therapy for various inflammatory diseases.

JOURNAL OF IMMUNOLOGICAL METHODS (2021)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

Recurrent Clostridioides difficile Infection Is Associated With Impaired T Helper Type 17 Immunity to C difficile Toxin B

Laura Cook, William D. Rees, May Q. Wong, William W. Kwok, Megan K. Levings, Theodore S. Steiner

GASTROENTEROLOGY (2021)

添加到收藏夹

Article Critical Care Medicine

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

Francois-Xavier Lescure, Hitoshi Honda, Robert A. Fowler, Jennifer Sloane Lazar, Genming Shi, Peter Wung, Naimish Patel, Owen Hagino

Summary: This study aimed to evaluate the safety and efficacy of sarilumab in patients with severe or critical COVID-19, but found no significant efficacy in patients admitted to the hospital receiving supplemental oxygen. Future adequately powered trials of targeted immunomodulatory therapies with survival as a primary endpoint are suggested for patients with critical COVID-19.

LANCET RESPIRATORY MEDICINE (2021)

添加到收藏夹

Article Cell Biology

An in vitro chronic damage model impairs inflammatory and regenerative responses in human colonoid monolayers

William D. Rees, Nikita Telkar, David T. S. Lin, May Q. Wong, Chad Poloni, Ayda Fathi, Michael Kobor, Nicholas C. Zachos, Theodore S. Steiner

Summary: We developed a chronic-injury model to study the effects of chronic intestinal damage on intestinal epithelial cells (IECs). We found that repeated rounds of damage impair the regrowth of IECs and their response to microbial stimulation. We also observed changes in mRNA expression and DNA methylation in genes associated with inflammatory bowel disease (IBD) and colon cancer.

CELL REPORTS (2022)

添加到收藏夹

Article Immunology

Phage display of environmental protein toxins and virulence factors reveals the prevalence, persistence, and genetics of antibody responses

Julia W. Angkeow, Daniel R. Monaco, Athena Chen, Thiagarajan Venkataraman, Sahana Jayaraman, Cristian Valencia, Brandon M. Sie, Thomas Liechti, Payam N. Farhadi, Gabriela Funez-dePagnier, Cheryl A. Sherman-Baust, May Q. Wong, Ingo Ruczinski, Patrizio Caturegli, Cynthia L. Sears, Patricia J. Simner, June L. Round, Priya Duggal, Uri Laserson, Theodore S. Steiner, Ranjan Sen, Thomas E. Lloyd, Mario Roederer, Andrew L. Mammen, Randy S. Longman, Lisa G. Rider, H. Benjamin Larman

Summary: Microbial exposures play a crucial role in impacting healthspan through shaping the immune system and microbiota. The use of Phage ImmunoPrecipitation Sequencing (PhIP-Seq) allows for high-throughput and cost-effective detection of exposure and response to microbial protein products. This study demonstrates that PhIP-Seq with the ToxScan library is an effective tool for studying the environmental determinants of health and disease at a cohort scale.

IMMUNITY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic

Tirosh Shapira, I. Abrrey Monreal, Sebastien P. Dion, David W. Buchholz, Brian Imbiakha, Andrea D. Olmstead, Mason Jager, Antoine Desilets, Guang Gao, Mathias Martins, Thierry Vandal, Connor A. H. Thompson, Aaleigha Chin, William D. Rees, Theodore Steiner, Ivan Robert Nabi, Eric Marsault, Julie Sahler, Diego G. Diel, Gerlinde R. Van de Walle, Avery August, Gary R. Whittaker, Pierre-Luc Boudreault, Richard Leduc, Hector C. Aguilar, Francois Jean

Summary: The COVID-19 pandemic caused by the SARS-CoV-2 virus is still a global public health crisis, with reduced efficacy of vaccination campaigns due to emerging variants of concern. Development of host-directed therapeutics and prophylactics can limit resistance and provide urgently needed protection against these variants.

NATURE (2022)

添加到收藏夹

Article Microbiology

Clostridioides difficile PCR Tcdb Cycle Threshold predicts toxin EIA positivity but not severity of infection

Regan Mah, Kerstin Locher, Theodore S. Steiner, Aleksandra Stefanovic

Summary: This study evaluated the real-time polymerase chain reaction (qPCR) cycle threshold (CT) as a predictor for disease severity and TcdB enzyme immunoassay (EIA) results. The results showed that CT value was an acceptable predictor for EIA toxin positivity but had limited predictability for clinical severity.

ANAEROBE (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication

Tirosh Shapira, Selvarani Vimalanathan, Celine Rens, Virginia Pichler, Sandra Pena-Diaz, Grace Jordana, William Rees, Dirk F. H. Winkler, Iqbal Sarai, Theodore Steiner, Francois Jean, Steven Pelech, Yossef Av-Gay

Summary: GSK3 beta inhibitors have shown broad-spectrum anti-coronaviridae activity, including against SARS-CoV-2, with low toxicity to host cells. A lead compound, T-1686568, exhibited dose-dependent activity against SARS-CoV-2 and HCoV-229E and showed efficacy in viral-infected cells and organoids. GSK3 beta and PKCa can phosphorylate the nucleocapsid protein of SARS-CoV-2, inhibiting its translation.

MOLECULAR BIOMEDICINE (2022)

添加到收藏夹

Review Cell Biology

Regenerative Intestinal Stem Cells Induced by Acute and Chronic Injury: The Saving Grace of the Epithelium?

William D. Rees, Rene Tandun, Enoch Yau, Nicholas C. Zachos, Theodore S. Steiner

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Patients' Willingness and Perspectives Toward Chimeric Antigen Receptor T-Regulatory Cell Therapy for Inflammatory Bowel Diseases

Jens Vent-Schmidt, Laurie J. Goldsmith, Theodore S. Steiner

CROHNS & COLITIS 360 (2020)

添加到收藏夹

暂无数据

Anti-flagellin antibodies in irritable bowel syndrome: another attack on our commensals?

期刊

出版社

WILEY-BLACKWELL

关键词

类别

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

评论

主要评分

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

推荐

导出引文

分享论文